COONasdaqOphthalmic GoodsFiscal year ends October 31
COOPER COMPANIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$58.16+0.22 (+0.38%)
Close on Oct 19, 2026
- Market cap
- $11.25B
- P/E (TTM)
- 19.8
- Dividend yield
- –
COOPER COMPANIES, INC. revenue by segment
By business segment
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coopervision Segment | $717.00M | $723.50M | $695.10M | $709.70M | $718.40M | $669.60M | $646.10M | $676.40M | $675.60M | $635.90M | $621.50M | $622.90M | 67.2% | -0.2% |
| CooperVision | $717.00M | $723.50M | $695.10M | $709.70M | $718.40M | $669.60M | $646.10M | – | – | – | – | – | 67.2% | -0.2% |
| Coopersurgical Segment | $349.20M | $358.00M | $329.00M | $355.40M | $341.90M | $332.70M | $318.60M | $342.00M | $327.20M | $306.70M | $310.10M | $304.20M | 32.8% | +2.1% |
| CooperSurgical | $349.20M | $358.00M | $329.00M | $355.40M | $341.90M | $332.70M | $318.60M | – | – | – | – | – | 32.8% | +2.1% |
| Operating income | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CooperVision | $205.50M | $215.60M | $210.20M | $156.70M | $202.60M | $186.40M | $183.90M | – | – | – | – | – | +1.4% |
| CooperSurgical | $41.10M | -$225.00M | $26.80M | $3.70M | -$4.20M | $23.70M | $20.20M | – | – | – | – | – | -1078.6% |
| Coopervision Segment | – | – | – | – | $202.60M | $186.40M | $183.90M | – | $172.70M | $160.20M | $154.80M | – | – |
| Coopersurgical Segment | – | – | – | – | -$4.20M | $23.70M | $20.20M | – | $41.30M | $21.60M | $24.00M | – | – |
By product or service
By region
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $519.50M | $547.80M | $513.90M | $526.20M | $516.20M | $515.20M | $496.40M | $505.30M | $511.20M | $479.00M | $470.40M | $471.80M | 48.7% | +0.6% |
| Europe | $357.50M | $341.60M | $326.40M | $330.70M | $343.10M | $291.90M | $287.50M | $305.60M | $297.00M | $276.70M | $276.60M | $263.80M | 33.5% | +4.2% |
| Rest of world | $189.20M | $192.10M | $183.80M | – | $201.00M | $195.20M | $180.80M | – | $194.60M | $186.90M | $184.60M | – | 17.7% | -5.9% |
From the segment and revenue-disaggregation notes of Cooper Companies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.